Copolymers of poly(lactic acid) and d-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy

Bibliography

• Bendix D. Chemical synthesis of polylactide and its copolymers for medical applications. Polym Degrad Stab 1998;59:129-35
   Web of Science ®Google Scholar
• Feng SS. Nanoparticles of biodegradable polymers for new-concept chemotherapy. Exp Rev Med Devices 2004;1:115-25
   PubMed Web of Science ®Google Scholar
• Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999;16:1550-6
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lee SH, Feng SS. Folate-decorated poly (lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials 2007;28:1889-99
   PubMed Web of Science ®Google Scholar
• Muthu MS, Feng SS. Nanopharmacology of liposomes developed for cancer therapy. Nanomedicine (Lond.) 2010;5:1017-19
   PubMed Web of Science ®Google Scholar
• Ma Y, Huang L, Song C, Nanoparticle formulation of poly(ϵ-caprolactone-co-lactide)-D-alpha-tocopheryl polyethylene glycol 1000 succinate random copolymer for cervical cancer treatment. Polymer (Guildf) 2010;51:5952-9
   Web of Science ®Google Scholar
• Wang J, Wang R, Li LB. Preparation and properties of hydroxycamptothecin-loaded nanoparticles made of amphiphilic copolymer and normal polymer. J Colloid Interface Sci 2009;336:808-13
   PubMed Web of Science ®Google Scholar
• Liang C, Yang Y, Ling Y, Improved therapeutic effect of folate-decorated PLGA–PEG nanoparticles for endometrial carcinoma. Bioorg Med Chem 2011;19:4057-66
   PubMed Web of Science ®Google Scholar
• Zhang Z, Feng SS. In vitro investigation on poly(lactide)-Tween 80 copolymer nanoparticles fabricated by dialysis method for chemotherapy. Biomacromolecules 2006;7:1139-46
   PubMed Web of Science ®Google Scholar
• He G, Ma LL, Pan J, ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and "stealth" particle characteristics. Int J Pharm 2007;334:48-55
   PubMed Web of Science ®Google Scholar
• Dong Y, Feng SS. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 2004;25:2843-9
   PubMed Web of Science ®Google Scholar
• Hu K, Li J, Shen Y, Lactoferrin-conjugated PEG–PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. J Control Release 2009;134:55-61
   PubMed Web of Science ®Google Scholar
• Venkatraman SS, Jie P, Min F, Micelle-like nanoparticles of PLA–PEG–PLA triblock copolymer as chemotherapeutic carrier. Int J Pharm 2005;298:219-32
   PubMed Web of Science ®Google Scholar
• Kunii R, Onishi H, Machida Y. Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin. Eur J Pharm Biopharm 2007;67:9-17
   PubMed Web of Science ®Google Scholar
• Essa S, Michel RJ, Hildgen P. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density. Int J Pharm 2011;411:178-87
   PubMed Web of Science ®Google Scholar
• Xiao L, Xiong X, Sun X, Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. Biomaterials 2011;32:5148-57
   PubMed Web of Science ®Google Scholar
• Zhang Z, Xiong X, Wan X, Cellular uptake and intracellular trafficking of PEG-b-PLA polymeric micelles. Biomaterials 2012;33:7233-40
   PubMed Web of Science ®Google Scholar
• Zhang CY, Yang YQ, Huang TX, Self-assembled pH-responsive MPEG-b-(PLA-co-PAE) block copolymer micelles for anticancer drug delivery. Biomaterials 2012;33:6273-83
   PubMed Web of Science ®Google Scholar
• Zhao ZX, Gao SY, Wang JC, Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine (R15) triblock copolymer for siRNA delivery. Biomaterials 2012;33:6793-807
   PubMed Web of Science ®Google Scholar
• Zhang Z, Feng SS. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials 2006;27:262-70
   PubMed Web of Science ®Google Scholar
• Zhanga Z, Feng SS. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)–tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 2006;27:4025-33
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lee SH, Gan CW, In vitro and in vivo investigation on PLA–TPGS nanoparticles for controlled and sustained small molecule chemotherapy. Pharm Res 2008;25(8):1925-35
   PubMed Web of Science ®Google Scholar
• Zhang Z, Feng SS. Self-assembled nanoparticles of poly (lactide) –Vitamin E-TPGS copolymers for oral chemotherapy. Int J Pharm 2006;324:191-8
   PubMed Web of Science ®Google Scholar
• Saul JM, Annapragada A, Natarajan JV, Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release 2003;92:49-67
   PubMed Web of Science ®Google Scholar
• Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000;41:147-62
   PubMed Web of Science ®Google Scholar
• Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant-tissues in vivo and in established cell-lines physiological and clinical implications. Cancer 1994;73:2432-43
   PubMed Web of Science ®Google Scholar
• Pan J, Feng SS. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. Biomaterials 2008;29:2663-72
   PubMed Web of Science ®Google Scholar
• Gan CW, Feng SS. Transferrin-conjugated nanoparticles of Poly(lactide)-D-alpha-Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Biomaterials 2010;31:7748-57
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Drug targeting to the brain. Pharm Res 2007;24:1733-44
   PubMed Web of Science ®Google Scholar
• Cohen BE, Bangham AD. Diffusion of small non-electrolytes across liposome membrane. Nature 1972;236:173-4
   PubMed Web of Science ®Google Scholar
• Bogman K, Zysset Y, Degen L, P-glycoprotein and surfactants: effect on intestinal talinolol absorption. Clin Pharmacol Ther 2005;77:24-32
   PubMed Web of Science ®Google Scholar
• Jones AR, Shusta EV. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res 2007;24:1759-71
   PubMed Web of Science ®Google Scholar
• Wagner E, Curiel D, Cotton M. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis. Adv Drug Deliv Rev 1994;14:113-35
   Web of Science ®Google Scholar
• Zhao J, Mi Y, Liu Y, Feng Y. Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend. Biomaterials 2012;33:1948-58
   PubMed Web of Science ®Google Scholar
• Briley-Saebo K, Bjørnerud A, Grant D, Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging. Cell Tissue Res 2004;316:315-23
   PubMed Web of Science ®Google Scholar
• Prashant C, Dipak M, Yang CT, Superparamagnetic iron oxide loaded poly (lactic acid) – D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent. Biomaterials 2010;31:5588-97
   PubMed Web of Science ®Google Scholar
• Wu XY, Liu HJ, Liu JQ, Immunofluorescent labeling of cancer marker Her 2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003;21:41-6
   PubMed Web of Science ®Google Scholar
• Wang YA, Li JJ, Chen HY, Stabilization of inorganic nanocrystals by organic dendrons. J Am Chem Soc 2002;124:2293-8
   PubMed Web of Science ®Google Scholar
• Pan J, Wang Y, Feng SS. Formulation, characterization and in vitro evaluation of quantum dots loaded in poly (lactide)-vitamin E TPGS nanoparticles for cellular and molecular imaging. Biotechnol Bioeng 2008;101:622-33
   PubMed Web of Science ®Google Scholar
• Jain RK. Delivery of molecular medicine to solid tumours: lessons from in vivo imaging of gene expression and function. J Control Release 2001;74:7-25
   PubMed Web of Science ®Google Scholar
• Pan J, Feng SS. Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers. Biomaterials 2009;30:1176-83
   PubMed Web of Science ®Google Scholar
• Tan YF, Chandrasekharan P, Maity D, Multimodal tumour imaging by iron oxides and quantum dots formulated in poly (lactic acid)-D-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles. Biomaterials 2011;32:2969-78
   PubMed Web of Science ®Google Scholar
• Sokol RJ, Butler-Simon N, Conner C, Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. Gastroenterology 1993;104:1727-35
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J Control Release 2002;80:129-44
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS. J Control Release 2003;86:33-48
   PubMed Web of Science ®Google Scholar
• Feng SS, Huang GF. Effects of phospholipids as emulsifiers on controlled release of paclitaxel from nanospheres of biodegradable polymers. J Control Release 2001;71:53-69
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharm Res 2003;20:1864-72
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan S, Feng SS. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 2012;33:4889-906
   PubMed Web of Science ®Google Scholar
• Yu L, Bridgers A, Polli J, Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res 1999;16:1812-17
   PubMed Web of Science ®Google Scholar
• Gelderblom H, Verweij J, Nooter K, Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001;37:1590-8
   PubMed Web of Science ®Google Scholar
• Singla AK, Garg A, Aggarwal D. Paclitaxel and its formulations. Int J Pharm 2002;235:179-92
   PubMed Web of Science ®Google Scholar
• Dorr RT. Pharmacology and toxicology of cremophor EL diluent. Ann Pharmacother 1994;28:S11-14
   PubMed Web of Science ®Google Scholar
• Fischer JR, Harkin KR, Freeman LC. Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine A in healthy dogs. Vet Ther 2002;3:465-73
   PubMedGoogle Scholar
• Mu L, Seow PH, Ang SN, Study on surfactant coating of polymeric nanoparticles for controlled delivery of anticancer drug. Colloid Polym Sci 2004;283:58-65
   Web of Science ®Google Scholar
• Feng SS, Zhao L, Zhang Z, Chemotherapeutic engineering: vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168 h in vivo. Chem Eng Sci 2007;62:6641-8
   Web of Science ®Google Scholar
• Moan J, Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 1991;53:549-53
   PubMed Web of Science ®Google Scholar
• Shieh M J, Hsu CY, Huang LY, Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells. J Control Release 2011;152:418-25
   PubMed Web of Science ®Google Scholar
• Greenwald RB, Choe YH, McGuire J, Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev 2003;55:217-50
   PubMed Web of Science ®Google Scholar
• Feng SS. New-concept chemotherapy by nanoparticles of biodegradable polymers – where are we now? Nanomedicine (Lond) 2006;1:297-309
   PubMed Web of Science ®Google Scholar
• Cao N, Feng SS. Doxorubicin conjugated to D-a-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials 2008;29:3856-65
   PubMed Web of Science ®Google Scholar
• Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumours based on EPR effects. Adv Drug Deliv Rev 2011;63:161-9
   PubMed Web of Science ®Google Scholar
• Xiong S, Yu B, Wu J, Preparation, therapeutic efficacy and intratumoural localization of targeted daunorubicin liposomes conjugating folate-PEG-CHEMS. Biomed Pharmacother 2011;65:2-8
   PubMed Web of Science ®Google Scholar
• Muthu MS, Feng SS. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success. Expert Opin Drug Deliv 2013; In press
   Web of Science ®Google Scholar
• Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006;58:1532-55
   PubMed Web of Science ®Google Scholar
• Abu Lila AS, Okada T, Doi Y, Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumour model: synergy or antagonism? Int J Pharm 2012;426:263-70
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Xiong J, Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm 2011;421:332-40
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Raju A, Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials 2012;33:3494-501
   PubMed Web of Science ®Google Scholar
• Wang T, Yin X, Lu Y, Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin. Int J Nanomedicine 2012;7:2325-37
   PubMed Web of Science ®Google Scholar
• Li YP, Xiao K, Luo JT, A novel size-tunable nanocarrier system for targeted anticancer drug delivery. J Control Release 2010;144:314-23
   PubMed Web of Science ®Google Scholar
• Gao Y, Li LB, Zhai G. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloids Surf B Biointerfaces 2008;64:194-9
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Liu Y, Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats. Nanomedicine (Lond) 2012;7:353-64
   PubMed Web of Science ®Google Scholar
• Chandrasekharan P, Maity D, Yong CX, Vitamin E (D-alpha-tocopheryl-co-poly(ethylene glycol) 1000 succinate) micelles superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI. Biomaterials 2011;32:5663-72
   PubMed Web of Science ®Google Scholar
• Mi Y, Liu Y, Feng SS. Formulation of docetaxel by folic acid-conjugated D-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy. Biomaterials 2011;32:4058-66
   PubMed Web of Science ®Google Scholar